Karyopharm Therapeutics Cash on Hand 2012-2024 | KPTI

Karyopharm Therapeutics cash on hand from 2012 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Karyopharm Therapeutics Annual Cash on Hand
(Millions of US $)
2024 $109
2023 $192
2022 $279
2021 $235
2020 $252
2019 $263
2018 $328
2017 $147
2016 $130
2015 $176
2014 $206
2013 $156
2012 $0
2011 $7
Karyopharm Therapeutics Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $109
2024-09-30 $134
2024-06-30 $152
2024-03-31 $149
2023-12-31 $192
2023-09-30 $209
2023-06-30 $237
2023-03-31 $261
2022-12-31 $279
2022-09-30 $149
2022-06-30 $172
2022-03-31 $206
2021-12-31 $235
2021-09-30 $207
2021-06-30 $237
2021-03-31 $225
2020-12-31 $252
2020-09-30 $264
2020-06-30 $299
2020-03-31 $353
2019-12-31 $263
2019-09-30 $268
2019-06-30 $217
2019-03-31 $264
2018-12-31 $328
2018-09-30 $207
2018-06-30 $241
2018-03-31 $131
2017-12-31 $147
2017-09-30 $120
2017-06-30 $144
2017-03-31 $110
2016-12-31 $130
2016-09-30 $127
2016-06-30 $123
2016-03-31 $136
2015-12-31 $176
2015-09-30 $195
2015-06-30 $221
2015-03-31 $246
2014-12-31 $206
2014-09-30 $227
2014-06-30 $132
2014-03-31 $145
2013-12-31 $156
2013-09-30 $53
2013-06-30 $18
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2011-12-31 $7
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.063B $0.145B
Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $98.106B 36.80
Zoetis (ZTS) US $70.247B 26.59
Daiichi Sankyo, - (DSNKY) JP $49.445B 25.16
Takeda Pharmaceutical (TAK) JP $48.747B 10.79
Summit Therapeutics (SMMT) US $20.720B 0.00
Sandoz Group AG (SDZNY) CH $19.545B 0.00
Merck (MKKGY) DE $18.346B 15.18
Shionogi (SGIOY) JP $14.436B 14.46
United Therapeutics (UTHR) US $13.289B 11.76
Neurocrine Biosciences (NBIX) US $10.852B 33.34
IPSEN (IPSEY) FR $9.920B 0.00
Orion OYJ (ORINY) FI $8.948B 24.20
Corcept Therapeutics (CORT) US $7.717B 58.69
Madrigal Pharmaceuticals (MDGL) US $7.005B 0.00
Stevanato Group S.p.A (STVN) IT $6.475B 41.12
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.217B 0.00
Grifols, S.A (GRFS) ES $5.054B 0.00
Soleno Therapeutics (SLNO) US $3.755B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.161B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.029B 12.30
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.470B 13.51
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.291B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.868B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.813B 0.00
Indivior (INDV) US $1.652B 7.01
Guardian Pharmacy Services (GRDN) US $1.632B 0.00
Evotec AG (EVO) DE $1.523B 0.00
ARS Pharmaceuticals (SPRY) US $1.420B 180.75
Ocular Therapeutix (OCUL) US $1.402B 0.00
Dyne Therapeutics (DYN) US $1.348B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.122B 45.61
Enliven Therapeutics (ELVN) US $1.006B 0.00
Ardelyx (ARDX) US $0.984B 0.00
Harrow (HROW) US $0.948B 0.00
Collegium Pharmaceutical (COLL) US $0.888B 4.72
Avadel Pharmaceuticals (AVDL) IE $0.840B 0.00
Xencor (XNCR) US $0.801B 0.00
AleAnna (ANNA) US $0.758B 0.00
Xeris Biopharma Holdings (XERS) US $0.737B 0.00
Cronos Group (CRON) CA $0.709B 0.00
KalVista Pharmaceuticals (KALV) US $0.674B 0.00
Organogenesis (ORGO) US $0.670B 0.00
Akebia Therapeutics (AKBA) US $0.641B 0.00
Bioventus (BVS) US $0.601B 15.62
Savara (SVRA) US $0.587B 0.00
USANA Health Sciences (USNA) US $0.555B 11.92
Relay Therapeutics (RLAY) US $0.554B 0.00
Regulus Therapeutics (RGLS) US $0.520B 0.00
Theravance Biopharma (TBPH) KY $0.519B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.474B 0.00
Verve Therapeutics (VERV) US $0.463B 0.00
Elite Pharmaceuticals (ELTP) US $0.453B 0.00
Altimmune (ALT) US $0.444B 0.00
Zevra Therapeutics (ZVRA) US $0.437B 0.00
Tourmaline Bio (TRML) US $0.419B 0.00
CytoDyn (CYDY) US $0.405B 0.00
Siga Technologies (SIGA) US $0.402B 6.87
Oruka Therapeutics (ORKA) US $0.401B 0.00
Heron Therapeutics (HRTX) US $0.352B 0.00
Rigel Pharmaceuticals (RIGL) US $0.346B 20.60
Aquestive Therapeutics (AQST) US $0.298B 0.00
Avita Medical (RCEL) US $0.244B 0.00
Wellgistics Health (WGRX) US $0.232B 0.00
ProKidney (PROK) US $0.231B 0.00
Nature's Sunshine Products (NATR) US $0.231B 27.15
Esperion Therapeutics (ESPR) US $0.216B 27.25
OmniAb (OABI) US $0.214B 0.00
Korro Bio (KRRO) US $0.197B 0.00
Larimar Therapeutics (LRMR) US $0.190B 0.00
MediWound (MDWD) IL $0.186B 0.00
4D Molecular Therapeutics (FDMT) US $0.174B 0.00
Aldeyra Therapeutics (ALDX) US $0.168B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Journey Medical (DERM) US $0.162B 0.00
Nanobiotix S.A (NBTX) FR $0.157B 0.00
Profound Medical (PROF) CA $0.157B 0.00
Aclaris Therapeutics (ACRS) US $0.156B 0.00
Lexeo Therapeutics (LXEO) US $0.154B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.151B 46.61
Procaps Group, S.A (PROCF) LU $0.141B 0.00
Nektar Therapeutics (NKTR) US $0.140B 0.00
Protara Therapeutics (TARA) US $0.138B 0.00
Lyell Immunopharma (LYEL) US $0.136B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.129B 0.00
Enanta Pharmaceuticals (ENTA) US $0.127B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
VAXART, INC (VXRT) US $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.095B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.094B 0.00
Achieve Life Sciences (ACHV) CA $0.089B 0.00
Galectin Therapeutics (GALT) US $0.088B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Dominari Holdings (DOMH) US $0.083B 0.00
Champions Oncology (CSBR) US $0.080B 13.11
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Pyxis Oncology (PYXS) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.078B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Fractyl Health (GUTS) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.077B 0.00
ESSA Pharma (EPIX) CA $0.077B 0.00
Nutriband (NTRB) US $0.071B 0.00
Inotiv (NOTV) US $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.063B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Gain Therapeutics (GANX) US $0.061B 0.00
Metagenomi (MGX) US $0.060B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Avalo Therapeutics (AVTX) US $0.054B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
ElectroCore (ECOR) US $0.049B 0.00
Century Therapeutics (IPSC) US $0.047B 0.00
Mural Oncology (MURA) IE $0.046B 0.00
Acrivon Therapeutics (ACRV) US $0.044B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
SCYNEXIS (SCYX) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
Prelude Therapeutics (PRLD) US $0.039B 0.00
Rafael Holdings (RFL) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.035B 0.00
FibroGen (FGEN) US $0.034B 0.00
Surrozen (SRZN) US $0.033B 0.00
PolyPid (PYPD) IL $0.028B 0.00
Tempest Therapeutics (TPST) US $0.026B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
BioVie (BIVI) US $0.022B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.021B 0.00
Mannatech (MTEX) US $0.020B 7.75
DURECT (DRRX) US $0.019B 0.00
Natural Alternatives (NAII) US $0.018B 0.00
Lipocine (LPCN) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
Cosmos Health (COSM) US $0.012B 0.00
Relmada Therapeutics (RLMD) US $0.012B 0.00
TransCode Therapeutics (RNAZ) US $0.012B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.95
BioLineRx (BLRX) IL $0.011B 0.00
Plus Therapeutics (PSTV) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.011B 0.00
Carisma Therapeutics (CARM) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.19
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Jaguar Animal Health (JAGX) US $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Ainos (AIMD) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Citius Pharmaceuticals (CTXR) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00